The rationale for computing the valence of phosphate in parenteral solutions is presented, and the dependence of this variable on pH and ionic strength is graphically illustrated. In view of valence considerations, several commonly employed methods of expressing the phosphate content in injectables are examined for their merit. Some definite recommendations are offered regarding the appropriateness of these different methods of phosphate quantification.
Get full access to this article
View all access options for this article.
References
1.
TurcoS. J.BurkeW. A.: Methods of Ordering and Use of Intravenous Phosphate (mEq vs mM), Hosp. Pharm.10: 320–326 (Aug.) 1975.
2.
LentzR. D.BrownD. M.KjellstrandC. M.: Treatment of Severe Hypophosphatemia, Ann. Intern. Med.89: 941–944 (Dec.) 1978.
3.
StecherP. G. (ed.): The Merck Index, 8th edition, Merck and Co., Inc., Rahway, NJ, 1968, p. 824.
4.
MorrisK.: Principles of Chemical Equilibrium, Van Nostrand Reinhold Co., New York, NY, 1965, pp. 42–55.
5.
ButlerJ. N.: Solubility and pH Calculations, Addison-Wesley Publishing Co., Inc., Reading, MA, 1964, p. 7.
6.
WeisbergH. F.: Water, Electrolyte, and Acid-Base Balance, The Williams and Wilkins Co., Baltimore, MD, 1962, p. 9.
7.
HillF. S.: Practical Fluid Therapy in Pediatrics, W. B. Saunders Co., Philadelphia, PA, 1955, p. 18.
8.
KiellandJ.: Individual Activity Coefficients in Aqueous Solutions, J. Am. Chem. Soc.59: 1675–1678 (Sept.) 1937.
9.
ScatchardG.BreckenridgeR. C.: Isotonic Solutions. II. The Chemical Potential of Water in Aqueous Solutions of Potassium and Sodium Phosphates and Arsenates at 25°, J. Phys. Chem.58: 596–602 (Aug.) 1954.
